It has been advocated that the pathogenesis may involve tissue factors and tumor-associated cysteine protease activity, tumor hypoxia, carcinoma mucin activity associated with platelet aggregation, and oncogene activation related to hypercoagulability [1]. This evidence concerns the gene CTSB and neoplasm.